Psychotic Disorders - Pakistan

  • Pakistan
  • Revenue in the Psychotic Disorders market is projected to reach US$31.26m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.79%, resulting in a market volume of US$32.52m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$2,257.00m in 2024).
  • In relation to total population figures, per person revenues of US$18.47 are generated in 2024.

Key regions: Japan, Australia, Europe, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Psychotic Disorders market in Pakistan is experiencing significant growth due to a variety of factors.

Customer preferences:
In Pakistan, there is an increasing awareness and recognition of mental health issues, including psychotic disorders. This has led to a growing demand for effective treatments and therapies. Customers are seeking out medications and therapies that can help manage symptoms and improve quality of life. Additionally, there is a preference for treatments that are affordable and easily accessible.

Trends in the market:
One of the key trends in the Psychotic Disorders market in Pakistan is the increasing availability and use of antipsychotic medications. These medications are commonly prescribed to manage symptoms such as hallucinations, delusions, and disordered thinking. The market is seeing a rise in the number of pharmaceutical companies offering antipsychotic medications, as well as an increase in the availability of generic versions of these drugs. This has made treatment more affordable and accessible for patients.Another trend in the market is the growing adoption of psychotherapy as a complementary treatment for psychotic disorders. Psychotherapy, such as cognitive behavioral therapy, can help individuals manage their symptoms and improve their overall well-being. There is an increasing number of mental health professionals in Pakistan who are trained in providing psychotherapy for psychotic disorders, and this has contributed to the growing popularity of this treatment option.

Local special circumstances:
Pakistan has a large population, and mental health issues, including psychotic disorders, are prevalent. The country has a shortage of mental health professionals, which has led to a significant treatment gap. However, there has been a push to address this issue, with the government and non-governmental organizations working to improve access to mental health services. This includes initiatives to train more mental health professionals and increase the availability of mental health clinics and hospitals.

Underlying macroeconomic factors:
Pakistan has been experiencing economic growth in recent years, which has led to an increase in healthcare spending. This has benefited the Psychotic Disorders market, as more resources are being allocated to mental health services and treatments. Additionally, the government has recognized the importance of addressing mental health issues and has implemented policies to support the development of the mental health sector.In conclusion, the Psychotic Disorders market in Pakistan is growing due to increasing customer preferences for effective and accessible treatments, as well as the availability of antipsychotic medications and the adoption of psychotherapy. Special circumstances, such as the shortage of mental health professionals, are being addressed through government and non-governmental initiatives. The underlying macroeconomic factors, including economic growth and government support, are also contributing to the development of the market.

Methodology

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Patients
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)